Microbot Medical Inc. (NASDAQ: MBOT) filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 25, 2026. The filing details the company's dissemination of a press release to update its growth strategies.
The press release, filed as Exhibit 99.1 to the 8-K, outlines specific operational changes. The company announced plans to add sales staff and expand its commercial footprint in the western region of the United States.
Microbot Medical Inc. is incorporated in Delaware and is headquartered at 175 Derby St., Bld. 27, in Hingham, Massachusetts. The company’s common stock trades on the NASDAQ Capital Market under the ticker symbol MBOT.
